Houston Concierge Medicine Partners With Cardio Diagnostics to Offer the Epi+Gen CHD Test in Their Executive Health Program
Thu Aug 10 2023 | press-releases
HOUSTON – Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), a leading precision cardiovascular diagnostics company, and Houston Concierge Medicine, a leading medical practice serving executives and health-forward consumers in Houston, today announced the use of Cardio Diagnostics’ Epi+Gen CHD test. This test, which combines epigenetics, genetics, high-throughput computing, and AI to identify those at risk for coronary heart disease, is now available to Houston Concierge Medicine patients as part of their Executive Health Program.
read more